找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response; Federico Innocenti Book 2009 Humana Press 2009 DNA.Dro

[復制鏈接]
查看: 10621|回復: 59
樓主
發(fā)表于 2025-3-21 18:21:23 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
編輯Federico Innocenti
視頻videohttp://file.papertrans.cn/383/382914/382914.mp4
概述Comprehensive reference for researchers in the field of cancer pharmacogenomics and clinicians, from both academia and industry.Provides a collection of multi-disciplinary topics.Covers the most impor
叢書名稱Cancer Drug Discovery and Development
圖書封面Titlebook: Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response;  Federico Innocenti Book 2009 Humana Press 2009 DNA.Dro
描述Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response provides the most comprehensive body of knowledge available on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. As a consequence of the intrinsic chromosomal and genetic instability of the tumor genome, it is generally believed that tailoring of chemotherapy in cancer - tients might be achieved by molecular analysis of patient tumor DNA. In addition, to reduce the toxicity risk of patients, the tumor DNA information should be in- grated with the available data on polymorphic drug-metabolizing enzyme and tra- porter genes mediating the exposure of patients to active drugs and/or their active metabolites. The chapters of this book clearly show how DNA information from both the host (germline) and the tumor should be taken into account for rational selection of drug therapies in cancer patients, an aspect that received little attention, despite its importance. The availability of new molecular approaches to the selection of drug therapy is an emerging need, because the traditional approach based on the evaluation of patient and tumor characteristic
出版日期Book 2009
關鍵詞DNA; Drogen; MicroRNAs; Microarrays; Oncology drug development; Pharmacogenomics; Single Nucleotide Polymo
版次1
doihttps://doi.org/10.1007/978-1-60327-088-5
isbn_softcover978-1-61737-694-8
isbn_ebook978-1-60327-088-5Series ISSN 2196-9906 Series E-ISSN 2196-9914
issn_series 2196-9906
copyrightHumana Press 2009
The information of publication is updating

書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response影響因子(影響力)




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response影響因子(影響力)學科排名




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response網(wǎng)絡公開度




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response網(wǎng)絡公開度學科排名




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response被引頻次




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response被引頻次學科排名




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response年度引用




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response年度引用學科排名




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response讀者反饋




書目名稱Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 20:31:29 | 只看該作者
Pharmacogenomics of the National Cancer Institute’s 60-Tumor Cell Panelmerged with drug chemosensitivity data to both elucidate a drug’s mechanism of action and to find cancer-specific targets. This framework offers a rational design strategy to mine novel anti-cancer candidates that are both potent and show specificity to targets in cancer pathways.
板凳
發(fā)表于 2025-3-22 01:51:58 | 只看該作者
Use of Single-Nucleotide Polymorphism Array for Tumor Aberrations in Gene Copy Numbersovements in software for copy number measurement using SNP arrays. The unique ability of the SNP array to determine both the genotype and copy number has uncovered novel DNA amplification events that involve only a single allele.
地板
發(fā)表于 2025-3-22 08:12:36 | 只看該作者
5#
發(fā)表于 2025-3-22 09:57:23 | 只看該作者
6#
發(fā)表于 2025-3-22 16:11:05 | 只看該作者
Role of Thymidylate Synthase Gene Variations in Colorectal Cancer Patientse (TS) mRNA and protein expression significantly correlates with sensitivity and resistance to TS-targeted 5-FU based chemotherapy regimens. However, the cause of the variability in TS expression still remains unclear, even though several molecular mechanisms have been identified that seem to regula
7#
發(fā)表于 2025-3-22 20:05:09 | 只看該作者
Impact of Polymorphisms on the Clinical Outcomes of Monoclonal Antibody Therapy Against Hematologic r impact on treatment outcomes in hematologic malignancies including follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), Waldenstrom’s macroglobulinemia (WM), and chronic lymphocytic leukemia (CLL). In addition, we discuss the approaches augmenting its clinical activity, especially focu
8#
發(fā)表于 2025-3-22 23:58:45 | 只看該作者
9#
發(fā)表于 2025-3-23 03:25:03 | 只看該作者
10#
發(fā)表于 2025-3-23 07:28:42 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 14:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
江津市| 阿尔山市| 大田县| 东港市| 伊宁县| 亳州市| 安西县| 贵定县| 天门市| 红安县| 西充县| 建德市| 长沙县| 蓬溪县| 云浮市| 安顺市| 凯里市| 怀化市| 惠东县| 灵山县| 河间市| 余姚市| 乐至县| 台前县| 吴桥县| 仁布县| 东阳市| 乌鲁木齐县| 锡林浩特市| 财经| 乐山市| 玛沁县| 团风县| 梓潼县| 宁海县| 岑巩县| 宝鸡市| 平凉市| 葫芦岛市| 方城县| 永川市|